![Christina Rossi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
Christina Rossi is currently Director at CG Oncology, Inc. since 2025.
Former roles include Independent Director at Xilio Therapeutics, Inc. from 2021 to 2026; Chief Operating Officer at Blueprint Medicines Corp.
from 2022 to 2025; Head-Multiple Sclerosis Business Unit at Genzyme Corp.
from 2012 to 2018; Head-Multiple Sclerosis Business North America at Genzyme Therapeutics Ltd. from 2016 to 2018; and Head-Commercial Strategy at Eidetica Biopharma GmbH from 2005 to 2010.
Education includes an undergraduate degree from Duke University in 1997 and an MBA from Harvard Business School in 2003.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CG ONCOLOGY, INC. -.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CG ONCOLOGY, INC. | Director/Miembro de la Junta | 24/11/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Director/Miembro de la Junta | 15/04/2026 |
| BLUEPRINT MEDICINES CORPORATION | Director de Operaciones | 01/01/2025 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/10/2018 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | 01/10/2018 |
Eidetica Biopharma GmbH
 Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical drugs | Corporate Officer/Principal | 01/01/2010 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Eidetica Biopharma GmbH
Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical drugs | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
